| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V1582 | AZD7762 | 860352-01-8 | AZD7762 (AZD-7762; AZD 7762) is a selective and ATP-competitive inhibitor of Chk1 (checkpoint kinases) with potential anticancer activity. |
|
V2732 | CCT245737 | 1489389-18-5 | CCT245737 (CCT-245737) is a novel, potent, orally bioavailable and selective ATP-competitive inhibitor of CHK1 (checkpoint kinase 1) with anticancer activity. |
|
V1585 | CHIR-124 | 405168-58-3 | CHIR-124 (CHIR124; CHIR 124) is a novel, potent and selective quinolone-based small molecule Chk1 (Checkpoint kinase1) inhibitor with potential anticancer activity. |
|
V131526 | CHK1-IN-12 | 2871056-82-3 | CHK1-IN-12 is an orally active and highly selective checkpoint kinase 1 (CHK1) inhibitor with an in vitro enzyme IC50 ≤ 10 nM and a cellular IC50 ≤ 50 nM. |
|
V3119 | Chk2 Inhibitor II (BML-277) | 516480-79-8 | Chk2 Inhibitor II (also known as BML-277) is an ATP-competitive inhibitor of Chk2 (checkpoint kinase 2) with an IC50 of 15 nM. |
|
V3690 | GDC-0575 (ARRY-575, RG7741) | 1196541-47-5 | Chk2 Inhibitor II (also known as BML-277) is an ATP-competitive inhibitor of Chk2 (checkpoint kinase 2) with an IC50 of 15 nM. |
|
V1584 | MK-8776 (SCH 900776) | 891494-63-6 | MK-8776 (also known as SCH900776;MK8776;SCH-900776;MK 8776) is a novel, highly potent and selective Chk1 (cell cycle checkpoint kinase 1) inhibitor with potential antineoplastic, radiosensitization and chemosensitization activities. |
|
V1586 | PF-477736 (PF-00477736) | 952021-60-2 | PF-477736 (also known as PF-736; PF-00477736; PF477736) is a novel, selective, potent and ATP-competitive Chk1 inhibitor with potential antitumor activity. |
|
V114828 | Prexasertib-d4 | Prexasertib-d4 (LY2606368-d4) is a deuterated derivative of Prexasertib. | |
|
V98023 | PV1162 | 1346559-65-6 | PV1162 is a selective Chk2 inhibitor with IC50 of 0.29 nM. |
|
V1583 | Rabusertib (LY2603618) | 911222-45-2 | Rabusertib (also known as IC-83;LY-2603618; LY 2603618;IC83) is a novel, potent and selective Chk1 (cell cycle checkpoint kinase 2) inhibitor with potential antitumor activity. |
|
V28897 | SCH900776 S-isomer (MK-8776 S-isomer) | 891494-64-7 | SCH900776 S-isomer is the S-isomer of SCH900776 (MK-8776), whichis a novel, highly potent and selective Chk1 (cell cycle checkpoint kinase 1) inhibitor with IC50 of 3 nM in a cell-free assay. |
|
V147345 | Zimistobart | 2829290-06-2 | Zimistobart is a fully human IgG1 antibody that targets NKG2A. |